|
🐜
|
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
47 auth.
S. Simpson-Yap,
E. De Brouwer,
T. Kalincik,
N. Rijke,
J. Hillert,
Clare Walton,
G. Edan,
Y. Moreau,
T. Spelman,
L. Geys,
T. Parciak,
Clément Gautrais,
Nikola Lazovski,
A. Pirmani,
Amin Ardeshirdavanai,
...
L. Forsberg,
A. Glaser,
R. McBurney,
H. Schmidt,
A. Bergmann,
S. Braune,
A. Stahmann,
R. Middleton,
A. Salter,
R. Fox,
A. van der Walt,
H. Butzkueven,
R. Alroughani,
S. Ozakbas,
J. Rojas,
I. van der Mei,
N. Nag,
R. Ivanov,
Guilherme Sciascia do Olival,
A. Dias,
M. Magyari,
D. Brum,
M. F. Mendes,
R. Alonso,
R. Nicholas,
J. Bauer,
A. Chertcoff,
Ana Zabalza,
G. Arrambide,
Alexander Fidao,
G. Comi,
L. Peeters
|
7 |
2021 |
7
🐜
|
|
🐬
|
Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients
N. Yozbatiran,
F. Başkurt,
Z. Başkurt,
S. Ozakbas,
E. İdiman
|
7 |
2006 |
7
🐬
|
|
🐢
|
Nitric oxide as an activity marker in multiple sclerosis
G. Acar,
F. Idiman,
E. İdiman,
Güldal Kirkali,
Handan Cakmakci,
S. Ozakbas
|
6 |
2003 |
6
🐢
|
|
🦁
|
Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis
S. Ozakbas,
I. Cagiran,
B. Ormeci,
E. İdiman
|
6 |
2004 |
6
🦁
|
|
🐜
|
Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample
8 auth.
E. İdiman,
Fatma Uzunel,
S. Ozakbas,
N. Yozbatiran,
Meral Oğuz,
Belgin Callioglu,
...
Nazan Gokce,
Z. Bahar
|
6 |
2006 |
6
🐜
|
|
🦁
|
Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features
S. Ozakbas,
E. İdiman,
B. Baklan,
B. Yuluğ
|
6 |
2003 |
6
🦁
|
|
🐜
|
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
44 auth.
T. Kalincik,
E. Kubala Havrdová,
D. Horáková,
G. Izquierdo,
A. Prat,
M. Girard,
P. Duquette,
P. Grammond,
M. Onofrj,
A. Lugaresi,
S. Ozakbas,
L. Kappos,
J. Kuhle,
M. Terzi,
J. Lechner-Scott,
...
C. Boz,
F. Grand'Maison,
J. Prevost,
P. Sola,
D. Ferraro,
F. Granella,
M. Trojano,
R. Bergamaschi,
E. Pucci,
R. Turkoglu,
P. Mccombe,
V. Pesch,
B. Van Wijmeersch,
C. Solaro,
C. Ramo-Tello,
M. Slee,
R. Alroughani,
B. Yamout,
V. Shaygannejad,
D. Spitaleri,
J. Sánchez-Menoyo,
R. Ampapa,
S. Hodgkinson,
R. Karabudak,
E. Butler,
S. Vucic,
V. Jokubaitis,
T. Spelman,
H. Butzkueven
|
6 |
2019 |
6
🐜
|
|
🐜
|
Risk of secondary progressive multiple sclerosis: A longitudinal study
63 auth.
A. Fambiatos,
V. Jokubaitis,
D. Horáková,
E. Kubala Havrdová,
M. Trojano,
A. Prat,
M. Girard,
P. Duquette,
A. Lugaresi,
G. Izquierdo,
F. Grand'Maison,
P. Grammond,
P. Sola,
D. Ferraro,
R. Alroughani,
...
M. Terzi,
R. Hupperts,
C. Boz,
J. Lechner-Scott,
E. Pucci,
R. Bergamaschi,
V. van Pesch,
S. Ozakbas,
F. Granella,
R. Turkoglu,
G. Iuliano,
D. Spitaleri,
P. Mccombe,
C. Solaro,
M. Slee,
R. Ampapa,
A. Soysal,
T. Petersen,
J. Sánchez-Menoyo,
F. Verheul,
J. Prevost,
Y. Sidhom,
B. Van Wijmeersch,
S. Vucic,
E. Cristiano,
M. Saladino,
N. Deri,
M. Barnett,
J. Olascoaga,
F. Moore,
O. Skibina,
O. Gray,
Y. Fragoso,
B. Yamout,
C. Shaw,
B. Singhal,
N. Shuey,
S. Hodgkinson,
A. Altıntaş,
T. Al-Harbi,
T. Csépány,
B. Taylor,
J. Hughes,
Jae-Kwan Jun,
A. van der Walt,
T. Spelman,
H. Butzkueven,
T. Kalincik
|
5 |
2019 |
5
🐜
|
|
🐢
|
Effect of video-based exergaming on arm and cognitive function in persons with multiple sclerosis: A randomized controlled trial.
A. T. Ozdogar,
Ozge Ertekin,
T. Kahraman,
P. Yiğit,
S. Ozakbas
|
5 |
2020 |
5
🐢
|
